Probe Before You Edit: Probing-Guided Molecular Optimization for LLM Agents in Structure-Based Drug Design
Researchers have developed a new framework called PROBE to improve molecular optimization for LLM agents in drug design. This method addresses the challenge of balancing binding affinity and druggability by first analyzing the pocket-ligand complex to identify areas where joint improvements are possible. PROBE then uses controlled probe edits and an 'EditManual' to guide an iterative multi-agent system, leading to state-of-the-art performance on the CrossDocked2020 benchmark. AI
IMPACT Introduces a novel framework to enhance LLM agent capabilities in structure-based drug design, potentially accelerating the discovery of new therapeutics.